Staying Sharp in San Francisco: Leading brain experts discuss successful aging

May 14, 2008

WHAT:
Brain function and health will be the focus of the Staying Sharp session on May 17 at St. Mary's Cathedral in San Francisco. Part of a highly recognized series, the program will emphasize successful aging, including how to deal with the booming aging industry; factors that predict future cognitive function; and the importance of clinical trials and how to participate in them.

WHO:
The program is sponsored by The Dana Alliance for Brain Initiatives, in partnership with NRTA: AARP's Educator Community and MetLife Foundation. Featured speakers will be: WHEN:
Saturday, May 17, 2008
10:00AM ¨C 12:00PM
(The event is free and open to the public)

WHERE:
St. Mary's Cathedral, Patron's Hall
1111 Gough Street (at Geary)
San Francisco, CA
-end-
The Dana Alliance for Brain Initiatives is a nonprofit organization of more than 265 leading neuroscientists, including ten Nobel laureates, committed to advancing public awareness about the progress and benefits of brain research. NRTA: AARP's Educator Community is America's foremost network of 50+ adults and organizations with a passion and affinity for education and learning. MetLife Foundation was established in 1976 by MetLife for the purpose of supporting educational, health and civic and cultural organizations

Staying Sharp is a series of public forums and educational booklets for older Americans. Since its inception in 1994, the series has been attended by more than 25,600 people in 26 cities across the United States. For more information, please visit: http://www.dana.org/danaalliances/programs/stayingsharp/

DANA Foundation

Related Clinical Trials Articles from Brightsurf:

Nearly 1 in 5 cancer patients less likely to enroll in clinical trials during pandemic
A significant portion of cancer patients may be less likely to enroll in a clinical trial due to the ongoing coronavirus pandemic.

COVID-19 clinical trials lack diversity
Despite disproportionately higher rates of COVID-19 infection, hospitalization and death among people of color, minority groups are significantly underrepresented in COVID-19 clinical trials.

Why we should trust registered clinical trials
In a time when we have to rely on clinical trials for COVID-19 drugs and vaccines, a new study brings good news about the credibility of registered clinical trials.

Inclusion of children in clinical trials of treatments for COVID-19
This Viewpoint discusses the exclusion of children from coronavirus disease 2019 (COVID-19) clinical trials and why that could harm treatment options for children.

Review evaluates how AI could boost the success of clinical trials
In a review publishing July 17, 2019 in the journal Trends in Pharmacological Sciences, researchers examined how artificial intelligence (AI) could affect drug development in the coming decade.

Kidney patients are neglected in clinical trials
The exclusion of patients with kidney diseases from clinical trials remains an unsolved problem that hinders optimal care of these patients.

Clinical trials beginning for possible preeclampsia treatment
For over 20 years, a team of researchers at Lund University has worked on developing a drug against preeclampsia -- a serious disorder which annually affects around 9 million pregnant women worldwide and is one of the main causes of death in both mothers and unborn babies.

Underenrollment in clinical trials: Patients not the problem
The authors of the study published this month in the Journal of Clinical Oncology investigated why many cancer clinical trials fail to enroll enough patients.

When designing clinical trials for huntington's disease, first ask the experts
Progress in understanding the genetic mutation responsible for Huntington's disease (HD) and at least some molecular underpinnings of the disease has resulted in a new era of clinical testing of potential treatments.

New ALS therapy in clinical trials
New research led by Washington University School of Medicine in St.

Read More: Clinical Trials News and Clinical Trials Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.